Angiotech Pharmaceuticals Inc. said Monday a stent it developed with Boston Scientific Corp. met its goals in a pair of clinical trials.
Angiotech said the Taxus Element stent worked as well as an older Boston Scientific stent called Taxus Express at treating lesions in blood vessels, and worked better than a different version of Express at preventing tissue from building up inside the stent.
Stents are mesh-metal tubes that are placed in blood vessels after they are surgically cleared of fatty plaque. Some stents, including Taxus Express, are coated with drugs to prevent scar tissue from blocking the vessel again.
Shares of the Vancouver-based …
No comments:
Post a Comment